2025 Non-GAAP Operating Loss Outlook: $17.2 million to $14 million. Xos Inc (NASDAQ:XOS) achieved significant year-over-year revenue growth in 2024, reflecting strong demand for their products.

"I hope it gets me so I can use my leg braces again." Physiotherapist Erica de Passillé said the exoskeleton allows patients to get more steps in than they normally would be able to. (Michael ...